Maglinger, Benton
Harp, Jordan P.
Frank, Jacqueline A.
Rupareliya, Chintan
McLouth, Christopher J.
Pahwa, Shivani
Sheikhi, Lila
Dornbos, David III
Trout, Amanda L.
Stowe, Ann M.
Fraser, Justin F.
Pennypacker, Keith R.
Funding for this research was provided by:
COBRE (P30GM127211)
Center for Clinical and Translational Science, University of Kentucky (Grant UL1TR001998)
Article History
Received: 10 September 2022
Accepted: 18 May 2023
First Online: 6 June 2023
Declarations
:
: This study involves human participants and was approved by the University of Kentucky Institutional Review Board (IRB) ID 48831. Consent was obtained for all subjects included in this study in the 72-h window outlined by the IRB. Typically, written consent was obtained either directly from the patient or family at the time of patient presentation, however, on occasion, consent was obtained over the phone in emergent settings, but then that was further documented on paper through email or fax. Both methodologies were approved by the IRB committee. This study adhered to the Declaration of Helsinki: the basic principles included respect for individuals, the right to make informed decisions, recognition of vulnerable groups, and more.
: All subjects have provided their consent. This manuscript has not been published elsewhere and is not under consideration by another journal.
: Authors KRP, AMS, and JFF are co-founders/equity holders in Cerelux, LLC. No others to report for any other coauthor.